1-8 of 8
JingWen Tan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and efficacy of IL-6 knockdown anti-CD19 CAR-T cells (ssCART-19) in the treatment of primary/secondary central nervous system lymphoma

Free
Wenjun Zhang, Xiyang Liu, Hongjia Zhu, Hongfei Gu, Fangce Wang, Chenbo Sun, Wei Zhang, Liqing Kang, Yi Ding, Jiayong Wang, Huan Zhou, Xue Lu, Xingyue Wang, Wei Wang, Zhou Yu, Jingwen Tan, Jing Ye, Israth Jahan Tuhin, Nan Xu, Xiaoyan Lou, Minghao Li, Shaoguang Li, Lei Yu, Peihua Lu, Aibin Liang
Journal: Blood
Blood (2025) 146 (Supplement 1): 927.
https://doi.org/10.1182/blood-2025-927
Published: 2025
Journal Articles

A novel loop-structured CD19/CD22 dual-targeting CAR-T therapy for patients with refractory/relapsed B-cell non-Hodgkin lymphoma

Free
Wei Zhang, Nan Xu, Hongfei Gu, Xiyang Liu, Liqing Kang, Hongjia Zhu, Xingyue Wang, Xue Lu, Huan Zhou, Wei Wang, Zhou Yu, Jingwen Tan, Jing Ye, Israth Jahan Tuhin, Xiaoyan Lou, Minghao Li, Lei Yu, Peihua Lu
Journal: Blood
Blood (2025) 146 (Supplement 1): 4152.
https://doi.org/10.1182/blood-2025-4152
Published: 2025
Journal Articles

Glofitamab use may significantly reduce the efficacy of CAR-T therapy in R/R DLBCL patients

Free
Xiyang Liu, Hongjia Zhu, Wei Zhang, Liqing Kang, Hongfei Gu, Xue Lu, Huan Zhou, Xingyue Wang, Nan Xu, Xiaoyan Lou, Minghao Li, Wei Wang, Zhou Yu, Jingwen Tan, Jing Ye, Israth Jahan Tuhin, Peihua Lu, Lei Yu
Journal: Blood
Blood (2025) 146 (Supplement 1): 2382.
https://doi.org/10.1182/blood-2025-2382
Published: 2025
Journal Articles

Enhanced homing and infiltration capabilities of CI9 cells improve treatment efficacy for T-cell acute lymphoblastic leukemia with extramedullary involvement

Free
Jinfeng Ma, Depei Wu, Nan Xu, Haiping Dai, Liqing Kang, Jingwen Tan, Haiguo Zhang, Ling Ye, Lei Yu, Xu Jia, Shengli Xue
Journal: Blood
Blood (2025) 146 (Supplement 1): 7643.
https://doi.org/10.1182/blood-2025-7643
Published: 2025
Journal Articles

Safety and efficacy of CD19/CD22/CD20 multi-targeted CAR-T therapy in patients with refractory/relapsed B-cell non-Hodgkin lymphoma

Free
Xiyang Liu, Liqing Kang, Hongfei Gu, Wei Zhang, Hongjia Zhu, Xue Lu, Huan Zhou, Xingyue Wang, Nan Xu, Xiaoyan Lou, Minghao Li, Wei Wang, Zhou Yu, Jingwen Tan, Jing Ye, Israth Jahan Tuhin, Lei Yu, Peihua Lu
Journal: Blood
Blood (2025) 146 (Supplement 1): 3713.
https://doi.org/10.1182/blood-2025-3713
Published: 2025
Journal Articles

Target Antigen-Expressing T Cells Facilitate CAR-T Cell Eradication of Residual CD19+ B Malignant Cells

Free
Minghao Li, Wenjie Gong, JingWen Tan, Hongjia Zhu, Nan Xu, Liqing Kang, Xiaoyan Lou, Wei Wang, Jing Ye, Zhou Yu, Israth Jahan Tuhin, Liyun Chen, Chongsheng Qian, Meijing Liu, Ni Mei, Tong Shi, Guanghua Chen, Lei Yu, Shengli Xue, Depei Wu
Journal: Blood
Blood (2024) 144 (Supplement 1): 4794.
https://doi.org/10.1182/blood-2024-206406
Published: 2024
Journal Articles

Long-Term Remission and Survival in Patients with Rituximab-Refractory/Relapsed B-Cell Non-Hodgkin Lymphoma after Treatment with U16 (CD20 CAR-T cells)

Free
Qian Cheng, JingWen Tan, Rui Liu, Liqing Kang, Hongjia Zhu, Yi Zhang, Erhua Wang, Ying Li, Jian Zhang, Han Xiao, Rong He, Xiaoyan Lou, Nan Xu, Wei Wang, Zhou Yu, Minghao Li, Hongfei Gu, Lei Yu, Xin Li
Journal: Blood
Blood (2024) 144 (Supplement 1): 3447.
https://doi.org/10.1182/blood-2024-200516
Published: 2024
Journal Articles

shRNA-Interleukin-6 Modified CD19-Specific Chimeric Antigen Receptor T Cell Significantly Improves the Safety in Acute Lymphoblastic Leukemia

Free
Liqing Kang, Xiaowen Tang, Nan Xu, Minghao Li, Jingwen Tan, Wei Qi, Zhou Yu, Xiaoyan Lou, Shengli Xue, Xin Li, MD, Jian Zhang, MD, Jia Chen, MD, Zhenkun Wang, PhD, Caixia Li, Fu Cheng Cheng, MD PhD, Depei Wu, MD PhD, Lei Yu, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2621.
https://doi.org/10.1182/blood-2019-132067
Published: 2019